ALFA News
Straight from the exchange filing
Every announcement Dr Reddys Laboratories has filed with the exchanges that we have reported, newest first. Each story links the original filing.
Every Dr Reddys Laboratories announcement on ALFA FilingsSee filings →Reference market data from a third-party provider, as of the most recent story. Not a valuation or a recommendation.
Dr. Reddy's Laboratories receives DCGI approval for Zytorvi for advanced esophageal cancer treatment in India. The drug reduced death risk by 42% in trials.
Dr. Reddy's partners with Takeda to distribute Qdenga, India's first approved dengue vaccine. Availability expected in H1 2027 for the private market.
Dr. Reddy's Laboratories launches generic Bosutinib Tablets 400mg in the U.S. with 180-day exclusivity, targeting a $253.8 million annual brand market size.
